We present a case of a previously well 24-year-old female patient who developed severe and life-threatening Irukandji syndrome that required ventilation and inotropic support. This case provides further evidence that there are jellyfish other than the Irukandji jellyfish that can cause cardiac decompensation, and there is a suggestion that application of a pressure immobilization bandage may worsen the envenomation. We include our recommended treatment for the Irukandji syndrome.
There exists only a handful of articles reporting cardiac failure [1] [2] [3] [4] as a result of presumed Irukandji jellyfish envenomation. We report a case of a 24-yearold female stung whilst swimming in the sea, who, within 4.5 hours, had signs and symptoms of severe Irukandji syndrome with significant cardiac dysfunction. She required ventilation for eight days and inotropic support for 72 hours. We believe this is the most severe case of Irukandji syndrome reported in the literature.
CASE PRESENTATION
A previously well 24-year-old female marine biologist was admitted to the Cairns Base Hospital, having been retrieved by helicopter from the Great Barrier Reef. While snorkelling (~1500 h), she felt herself being stung on the left arm and axilla, and anterior neck. By the time she returned to the boat she was experiencing worsening limb, abdominal and back pain. Ice and vinegar were liberally applied to the sting site and then a pressure immobilization bandage was applied to the stung limb. During the flight to the Emergency Department, her back and abdominal pain became more severe with diaphoresis and headache.
On arrival in the Emergency Department (~1825 h) she was markedly distressed. Her pulse was 110/min, blood pressure was 170/110 mmHg, respiratory rate 16/min and SpO 2 99% on room air. However within one hour of admission she had desaturated to SpO 2 84% on room air. An obvious wheal was evident on the left arm and neck when the pressure immobolization bandage was removed from the arm. She had evidence of significant left ventricular dysfunction with tachycardia, a third heart sound and crackles through her lung fields. A diagnosis was made of Irukandji syndrome.
Initial investigations including full blood count, urea and electrolytes, and cardiac troponin I were normal. Her creatine kinase (CK) was elevated at 180 U/l (<160). Her chest X-ray showed perihilar shadowing. An echocardiograph performed at six hours post envenomation demonstrated global left ventricular dysfunction with an ejection fraction of 35%.
Her management consisted of high-flow oxygen with a non-rebreather mask at 15 l/min and pethidine as she was in severe pain. She received intravenously 25 mg of promethazine, 25 mg aliquots of pethidine to a total of 200 mg, and then fentanyl.
She was admitted to the Intensive Care Unit, given frusemide and commenced on dobutamine and glyceryl trinitrate (GTN) infusions. Over the next six hours, despite increasing dosage of dobutamine (to CASE REPORT Anaesthesia and Intensive Care, Vol. 29, No. 2, April 2001 11.5 µg/kg/min) and GTN (to 23.3 µg/min) the patient had deteriorating cardiovascular function, (with BP 80/60 mmHg), and respiratory function (with SpO 2 of 89%). Adrenaline and bi-level positive pressure noninvasive ventilation were commenced, dobutamine and GTN were ceased. However, she did not tolerate noninvasive ventilation and was intubated 24 hours after envenomation. A post intubation chest X-ray revealed bilateral alveolar shadowing. A pulmonary artery catheter was placed soon after intubation. Initial readings below are listed in Table 1 and serial pulmonary artery catheter studies in Table 2 .
She was ventilated for eight days, with an FiO 2 >0.5 for five days. She remained on adrenaline for 72 hours with a maximal dose of 20 µg/min for 30 hours.
During her stay in ICU, her cardiac troponin I peaked at 72 µg/l (normal <0.7 µg/l) and her CK peaked at 5930 U/l. Serial echocardiograms showed improvement in cardiac function with a return to normal function prior to discharge.
An attempt to collect nematocysts with sticky tape of the sting site and examination with electron microscopy was unsuccessful. A small macerated tentacle was obtained from the sting site, which, due to its maceration, could not be accurately identified. However, our local marine biologist was confident that the tentacle did not come from an Irukandji jellyfish.
The patient was discharged to the ward 11 days after admission and discharged home on day 14. She has had no further symptoms of envenomation, and at three months post admission was gradually returning to normal activity.
DISCUSSION
Barnes 5 first identified the Irukandji jellyfish, Carukia barnesi, in 1964 in Cairns. The name Irukandji was first used by Flecker 6 in 1952 to describe the syndrome, and named after a local Cairns aboriginal tribe. Patients envenomated by the Irukandji demonstrate an array of symptoms including severe back pain, limb pain, muscular pains, chest and abdominal pain, nausea and vomiting, headache and sweating 4 . This is known as the Irukandji syndrome. Rarely, pulmonary oedema develops in people with the Irukandji syndrome, and has only been reported in a handful of cases [1] [2] [3] [4] . The Irukandji jellyfish has been implicated as the cause of pulmonary oedema. However this has not been proved, and it is suspected that other jellyfish may be responsible for the severe cases 2, 4 . The finding in our case of a tentacle not thought to be from a Carukia barnesi supports this hypothesis.
The Irukandji jellyfish is small, with a bell of 2.5 cm in diameter, however with tentacles of up to 1 m in length 4 . Due to its size and transparency it is rarely seen prior to envenomation 7 .
Irukandji syndrome is a common presentation to the Emergency Departments in Cairns. In 1996, 62 patients presented to Cairns hospitals, two of whom developed pulmonary oedema and required admission to high dependency areas 4 . Very little is known about the venom and currently no antivenom is available.
There have been no reported deaths in patients with the Irukandji syndrome, however this patient's presentation was the most life-threatening reported in the medical literature, requiring ventilation for eight days and inotropic support for 72 hours.
As in other cases reported 1-4 , our patient developed severe pain, with classically described symptoms of Irukandji syndrome very shortly after being stung. Despite having vinegar applied to the sting sites, her symptoms continued to worsen with the application of a pressure immobilization bandage to the left arm.
The application of pressure immobilization bandage in the treatment of jellyfish envenomation remains controversial. Although recommended by the Australian Resuscitation Council 8 , Queensland Ambulance Service 9 and Queensland Surf Life Saving Association 10 , the evidence is anecdotal, and is extrapolated from its use in the management of elapid snakebite 3 . Interestingly, it is not recommended by authorities in the Northern Territory 11 , and recent 12 suggests that pressure equal to that of a pressure immobilization bandage applied to discharged nematocysts actually releases more venom. We are concerned that the application of the pressure bandage may have worsened this patient's envenomation.
Usually the patients who develop pulmonary oedema do so about 12 hours after envenomation. However this patient had clinical evidence of left ventricular dysfunction within four and a half hours of envenomation, which was confirmed on echocardiography six hours after envenomation. Although the patient presented with hypertension (BP 170/110), as described in other cases 1,2 her echocardiogram revealed global left ventricular dysfunction with an ejection fraction of 35%. A pulmonary artery catheter was inserted 26 hours after envenomation and this demonstrated a markedly reduced cardiac index of 1.7 l/min/m 2 with a systemic vascular resistance index of 3055 dyn/s/cm 5 /m 2 . We postulate that the high SVRI at this latter stage is a sympathetic response to the low cardiac index.
The reason for the cardiac failure is not clear. Some authors 1, 2 have suggested that the venom may cause a release of catecholamines (like a phaeochromocytoma), or a direct toxic effect on the heart. Our data supports Martin's 1 suggestion that the venom probably causes direct myocardial injury, as evidenced by the poor ejection fraction, global ventricular dysfunction, markedly raised troponin I and creatine kinase, and the low cardiac output. Some authors 2,3 have suggested the hypertension that is seen on presentation should be treated with alpha blocking drugs such as phentolamine. The cause of the hypertension is not clear. Although it may be due to catecholamine release, these patients are in severe pain and this may well contribute. Furthermore this patient demonstrated significant left ventricular dysfunction within six hours of envenomation. We are concerned that administration of an alpha-blocking drug may cause marked hypotension, and therefore advocate early echocardiography and cardiovascular monitoring prior to the administration of such drugs.
Echocardiography and pulmonary artery catheterization are the best guide to the choice of inotrope. We found adrenaline increased the cardiac output and blood pressure and interestingly the SVRI fell despite doses of 0.35 µg/kg/min. In our Emergency Department, any patient who develops the Irukandji syndrome is observed closely and investigated and treated aggressively. Copious irrigation of the sting site with vinegar should be administered as soon as possible. Although traditionally 5 advocated, pethidine should not be used for pain relief due to the concerns of the potential myocardial depressive action of the venom. In our current Emergency Department protocol, fentanyl is the analgesic of choice 4 . As we believe that the cardiovascular complications of Irukandji syndrome may well be under-recognized, any person who has ongoing pain, or develops signs or symptoms of cardiac dysfunction requires cardiac monitoring and echocardiography. We would not acutely treat moderate hypertension, unless the patient developed cardiac failure and would strongly advocate cardiac echocardiography prior to cardiovascular manipulation.
